about
DIAGNOSIS OF ENDOCRINE DISEASE: Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysisLoss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargementThe IGSF1 deficiency syndrome: characteristics of male and female patientsRecurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis.Corticosteroid use and mortality risk in patients with perforated colonic diverticular disease: a population-based cohort study.Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.Widespread reductions of white matter integrity in patients with long-term remission of Cushing's diseaseGH replacement therapy in elderly GH-deficient patients: a systematic review.Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis.Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality.Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones.Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP miceHigh prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenomaRelationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes.Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma.The Role of the Suprachiasmatic Nucleus in Cardiac Autonomic Control during Sleep.High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomasResting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease.Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus.The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-PituitaryNanomedicines in the treatment of acromegaly: focus on pegvisomant.IGSF1 Deficiency: Lessons From an Extensive Case Series and Recommendations for Clinical Management.STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritabilityImpact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values.ACTH-producing pheochromocytoma: clinical considerations and concise review of the literature.Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical ParametersCopy number variants in patients with short stature.Effects of high fat diet on the Basal activity of the hypothalamus-pituitary-adrenal axis in mice: a systematic review.Treatment of nonfunctioning pituitary adenomas: what were the contributions of the last 10 years? A critical view.Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature.Alterations in diurnal rhythmicity in patients treated for nonfunctioning pituitary macroadenoma: a controlled study and literature review.Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies.Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis.
P50
Q28068699-EB0AC422-79EF-406A-A271-258484422AC5Q28279078-D836C17A-98C7-41C0-91C6-28F446EA98F5Q28300032-A4412846-6AE4-4E53-98BE-F970019585B6Q33514258-EA606535-582F-4A52-93D2-4BE143BF9D17Q33552652-CBFFA52E-3ABD-4858-9055-7BF6BC508E79Q33586753-D2D6889D-DBF2-4387-A793-2B45E0691DBBQ33741321-A57ACB97-8E63-4CA2-B88B-A96B0E0CF565Q33825949-B9077AE7-1701-4C32-87B5-BA2FD2157BC2Q33912364-BC146C4E-4CCB-4781-B98B-671C14ED90B6Q33973327-5A964C78-2F29-4EC4-BA26-E83068D77824Q34019857-B3717E1C-2E7F-4E64-AAD2-F5EE7FD1557FQ34461204-0D032CE3-AE8C-4B63-A5A9-6CC21879F52FQ34619927-F07582F2-EA10-43DA-917D-830312CF4CC9Q34744777-65DE5A4B-CCCD-4C0C-A1A8-E4141D12BB70Q35114788-ACD48958-0A83-468B-B1BC-13D22F39DE7FQ35285206-D594AD0A-7A19-4ADE-9EA2-B668BB750FCAQ35827530-B884D36F-377E-41DB-B064-2ED749B6A42DQ35884308-6EBA92D1-6FE4-4A78-9247-D97C9FA8CFDAQ35968867-8894A383-A2ED-4DFD-9BDE-7BDA32803ACBQ36019982-2C8B9CAA-4E3A-4427-A533-60B26654E68AQ36099625-C59F569B-772B-4003-9ABE-489979B59536Q36236874-C4985045-BA1D-4A19-B78C-635DC4BF8371Q36821767-A2DC7C72-8AA0-442F-BC14-18581A459D02Q36837304-005462A8-74B5-4B08-B659-8A8486FCD928Q36874748-5CD775D4-88E3-4E46-A7E0-E702019F71C3Q36920317-929893FB-E04D-404E-B7D0-AD4C121B78AFQ36935601-FFDCCAC1-20C2-43A3-8193-C96BC3AABF23Q36983024-D88E42CD-C4D6-45B3-9D5F-9EC673D54F47Q37543762-D03C417F-4ADC-4194-87B7-CF608A82DE74Q37604100-181C59C9-ABC1-4EB1-96C7-65D34FB5F5FDQ37612113-53F111C9-A6CA-472D-84A0-CC21A9B7DDCCQ37678328-97E25E1C-9763-417C-84FD-B07D5F23E2AAQ37711793-E3E1DDDE-CA6E-454A-8D4C-B9A064DBC91DQ37954156-C39F2CC5-8B80-448B-942F-8209022C3BF1Q38006186-DC34B152-565E-4B72-A2CC-A105870ACF1DQ38209773-27395570-895F-4A74-B4C8-9A727BA87A20Q38211663-49BD72F9-6D08-42E3-9D5B-27DA71288A49Q38326160-8F0F6454-664F-405E-B057-3E355CC1FD37Q38357447-03F917DF-ECD5-48F5-9E4B-1B59A9D82323Q38365739-1D71F5DA-B84D-4C46-AA4F-FFA126335FA5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alberto M Pereira
@en
Alberto Pereira
@es
Alberto Pereira
@nl
type
label
Alberto M Pereira
@en
Alberto Pereira
@es
Alberto Pereira
@nl
altLabel
A. Pereira
@nl
A.M. Pereira
@nl
Alberto M Pereira
@nl
Alberto M. Pereira
@en
prefLabel
Alberto M Pereira
@en
Alberto Pereira
@es
Alberto Pereira
@nl
P1053
Q-7175-2017
P106
P21
P31
P496
0000-0002-1194-9866